US 8008501
Quinoline compounds and their uses
granted A61PA61P43/00
Quick answer
US patent 8008501 (Quinoline compounds and their uses) held by Rigel Pharmaceuticals, Inc. expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P43/00